Page last updated: 2024-09-03

2',3'-dideoxycytidine 5'-triphosphate and Acquired Immune Deficiency Syndrome

2',3'-dideoxycytidine 5'-triphosphate has been researched along with Acquired Immune Deficiency Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Betageri, GV; Black, CD; Gartner, S; Parker, RJ; Popovic, M; Szebeni, J; Wahl, LM; Wahl, SM; Weinstein, JN1

Trials

1 trial(s) available for 2',3'-dideoxycytidine 5'-triphosphate and Acquired Immune Deficiency Syndrome

ArticleYear
Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes.
    AIDS research and human retroviruses, 1990, Volume: 6, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Antibodies; Antiviral Agents; Capsules; Cells, Cultured; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Deoxycytosine Nucleotides; Dideoxynucleotides; Drug Carriers; HIV-1; Humans; Immunoglobulin G; Kinetics; Liposomes; Macrophages; Monocytes; Virus Replication; Zalcitabine

1990